Pharmaceutical Company Settles 20 ANDA Litigation Matters

A pharmaceutical company settled 20 patent infringement abbreviated new drug application (ANDA) lawsuits involving one of its products. Alison Baldwin co-led litigation teams in the lawsuits, which were filed against defendants for the defendants’ anticipated marketing of a generic version of a drug.

The Faegre Baker Daniels website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Baker Daniels' cookies information for more details.